Retina Global Logo
  • Home
  • News
  • About
    • Objectives
    • Board
    • Advisory Board
  • Projects
    • Burundi
    • Belize
    • Bolivia
      • Bolivian Diabetic Retinopathy (#BOLDR) Project
      • Volunteer Retina Specialists for #BOLDR project
      • #BOLDR Curso de Certificación en Retinopatía Diabética
      • #BOLDR Certification Course in Diabetic Retinopathy
    • Bahamas
    • Haiti
    • Future projects
  • Knowledge
  • Join us
  • Support us

Poor Avastin responders in AMD & DME may have increased risk to obstructive sleep apnea

Posted on January 3, 2015January 3, 2015 by admin

Poor responders to Bevacizumab (Avastin) in patients with age-related macular degeneration (AMD) and diabetic macular edema (DME) may have increased risk to obstructive sleep apnea (OSA).

Read more…

Posted in Age-related Macular Degeneration.

Post navigation

← Retinal imaging may provide early…
Prof. Robin Ali on retinal… →
Retina Global

Location

PO Box 8012, Laguna Hills, CA 92654
USA

Contact

Phone: +1-949-281-6768

Email: info@retinaglobal.org

Policies

Legal
Advertisements
Disclaimer

© Retina Global 2012-2019. All rights reserved.
// © 2012-2019